Geoff Barnett, Managing Director, Chronic Therapies, Sciensus, leads commercial strategy and operations for the company’s chronic disease management portfolio across the UK. He is responsible for driving growth across Sciensus’ chronic therapy platforms, which provide integrated distribution, in-home clinical care and patient support services for complex, long-term treatments.
His strategic focus encompasses operational delivery of patient programmes, the development of innovative commercial models that accelerate product launches and optimise therapy adoption and the advancement of pharma partnerships. As a trusted operational partner to both NHS trusts and biopharma companies, Geoff has a deep understanding of the unique dynamics of the UK healthcare landscape enabling Sciensus to design solutions that address the specific challenges facing the NHS and patients. “Sciensus has demonstrated success in enhancing NHS’s ability to treat more patients, delivering improved journey and better outcomes, whilst simultaneously introducing cost-saving operational efficiencies that relieve capacity and staffing constraints”.
With over 25 years of experience in pharmaceutical services and healthcare commercialisation, he brings deep expertise in building strategic partnerships with biopharma clients, developing market access strategies and scaling patient-centred service delivery models.
Geoff joined Sciensus in 2017 as Business Development Director and has progressed through roles of increasing responsibility, including Director of Pharma Services and UK Commercial Director, consistently delivering growth in the company’s client portfolio and service capabilities. Prior to Sciensus, he held senior commercial leadership positions at Quintiles as Key Account Director, Bupa Home Healthcare as Head of Pharma Sales, Pfizer Pharmaceuticals as National Accounts Director and Bupa Health Dialog as Associate Director.
Geoff’s leadership combines commercial acumen with operational pragmatism, focused on delivering sustainable growth while maintaining quality and patient outcomes.